AI/ML for Early Drug Discovery Icon

Cambridge Healthtech Institute’s Inaugural

AI/ML for Early Drug Discovery

Improving Speed and Efficiency for Target Discovery, Drug Design, and Optimisation

4 - 5 DECEMBER 2024


Cambridge Healthtech Institute’s conference on Artificial Intelligence (AI)/Machine Learning (ML) for Early Drug Discovery offers case studies presented by experts in academia and industry showing how and where AI/ML has been integrated and implemented in drug discovery. Chemists, biologists, pharmacologists, and bioinformaticians will highlight how AI predictions, ML algorithms, and data science can help identify and validate drug targets, design and prioritise lead candidates for development, and enable data-driven decision-making.

For more details on the conference, please contact:

Tanuja Koppal, PhD

Senior Conference Director

Cambridge Healthtech Institute



For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431


Register Early and Save
Next-Gen Degraders & Molecular Glues
Protein-Protein Interactions

Learn About Our U.S. Event
Register Early and Save